Novel biomarkers assist in detection of liver fibrosis in HCV patients
Abstract Background Accurate staging in individuals infected with hepatitis C is imperative to understand their long-term risk for liver-related complications. Liver biopsy has a traditional role to determine the levels of liver fibrosis specifically in hepatitis C virus patients. However, the devel...
Guardado en:
Autores principales: | Tamer A. Addissouky, Yuliang Wang, Fayed Attia Koutb Megahed, Ayman E. El Agroudy, Ibrahim El Tantawy El Sayed, Abdel Moneim A. K. El-Torgoman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SpringerOpen
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d43205344ee94c458f1abe5fbd6d8336 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes
por: Page K, et al.
Publicado: (2019) -
Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
por: Atsushi Hosui, et al.
Publicado: (2021) -
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
por: Janardhan SV, et al.
Publicado: (2015) -
Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Osama Hamdy, et al.
Publicado: (2021) -
Hepatitis C infection in Egypt: prevalence, impact and management strategies [Corrigendum]
por: Gomaa A, et al.
Publicado: (2017)